The a2 Milk Company from New Zealand is deepening its focus on what it calls an "irreplaceable" Chinese market through a series of strategic investments and partnerships. The company has invested approximately 1.2 billion yuan to acquire the POKENO factory in New Zealand, a move expected to increase its core range of infant formula products with Chinese-language labels from one to three or four. This lays the foundation for expanding both online and offline sales channels and penetrating lower-tier markets, with related new products potentially launching as early as next year.

Simultaneously, a2 has significantly upgraded its strategic partnership with its "state-backed ally," China State Farms. The collaboration has expanded from exclusive distribution to cross-border e-commerce, with plans to jointly establish a2's first overseas research and development center in Shanghai. Currently, the partnership has already covered over 30,000 maternal and child stores through more than 100 distributors.

In terms of market performance, a2 delivered impressive results in the 2025 fiscal year, increasing its market share in China's infant formula sector to 8% and breaking into the top four for the first time. The company believes its brand philosophy, which emphasizes the easy digestibility and absorption of A2 protein, aligns with the needs of Chinese consumers and is key to its success. Despite facing broader market challenges, a2 remains confident about its future growth prospects.

0

打赏

表情 点击这里取消回复。